Clinical Trial Update: Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia [NA]

View source ↗

Summary

This completed clinical trial evaluated modafinil augmentation for excessive daytime sleepiness and negative symptoms in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: Veterans Medical Research Foundation | Conditions: Schizophrenia | NA | Status: COMPLETED